The FDA designated 166 products under its breakthrough devices program in its most recent financial year, reversing the ...

Xeltis, a leading developer of transformative implants that enable the natural creation of living and long-lasting vessels, today announces that the Center for Devices and Radiological Health (CDRH) ...

Xeltis has developed aXess to improve on infection and reintervention rates compared to other dialysis access approaches.

Detailed price information for Seastar Medical Hldg Corp (ICU-Q) from The Globe and Mail including charting and trades.

Researchers at University of California San Francisco (UCSF) have developed a single genomic test that can quickly detect ...

Johnson & Johnson announced that the U.S. Food and Drug Administration has granted nipocalimab Breakthrough Therapy designation for the ...

BioCardia Inc ( NASDAQ:BCDA) has received FDA breakthrough designation for its lead autologous cardiac cell therapy for heart ...

Plus, Donald Trump is set to visit the White House to meet with President Joe Biden for a symbolic meeting to signify a ...

To this end, we received notice last week from the FDA of Breakthrough Device Designation for the SCD in chronic dialysis. This is the fourth indication to receive this designation and the first for a ...

Vaxcyte (NASDAQ:PCVX) announced that the U.S. FDA cleared the VAX-31 infant Investigational New Drug application and granted ...

Researchers created a single-step device using redox electrodialysis and electrosorption to capture and destroy diverse PFAS ...